Expert Recommendations to Standardise Transcriptomic Analysis in Inflammatory Bowel Disease Clinical Trials

By sjmartinez • April 29, 2025

Linggi B, Salas A, Steere B, Verstockt B, Alsoud D, Casero D, McGovern D, Chan E, Smith MI, Ungaro F, Rieder F, Aden K, Shackelton LM, Massimino L, Neurath M, Allez M, Atreya R, Snapper SB, Raine T, Ahuja V, Haberman Y, Feagan BG, Jairath V, Casteele NV. Expert Recommendations to Standardise Transcriptomic Analysis in Inflammatory Bowel Disease Clinical Trials. J Crohns Colitis. 2025 Apr 29:jjaf068. doi: 10.1093/ecco-jcc/jjaf068. Epub ahead of print. PMID: 40295219.

Tags: Cedars Sinai DoM, clinical trials, Digestive Diseases, inflammatory bowel disease, Publications, transcriptomic analysis

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

O'Reilly EM, Wainberg ZA, Hendifar AE, Borad MJ, Pietrantonio F, Pant S, Hammel P, Cremolini C, Manji GA, Oberstein PE, Garrido-Laguna I, Springfeld C, Azad[...]

Artificial intelligence-enabled plaque characterization from coronary computed tomography establishes basis of angina in women with nonobstructive atherosclerosis

Wolny R, Flores Tomasino G, Grodecki K, Lenell J, Park C, Park R, Kwiecinski J, Dasa O, Calsavara V, Berman DS, Slomka PJ, Budoff MJ,[...]

Characterizing Abdominal Pain and Irritable Bowel Syndrome Among Individuals With Cirrhosis: Results of a Nationwide Survey

Deng LX, Almario CV, Lai JC, Spiegel BMR, Rubin JB. Characterizing Abdominal Pain and Irritable Bowel Syndrome Among Individuals With Cirrhosis: Results of a Nationwide[...]